Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Bullboard Posts
Comment by realtyon Jun 24, 2020 11:23am
103 Views
Post# 31185824

RE:RE:The last patient update was September 30, 2019

RE:RE:The last patient update was September 30, 2019Longholder99, So you are saying that since September 30, 2020, that they havent examined any of the patients from the first round of clinical trials to see if they were still good?  Are you also saying that they dont have any news at all to share about the results of any of the patiends in the second round of the trials.  I mean, you just said that we had this Corona Virus thing..  All of the TLTFF management and employees were all sitting at home for months correct?  Dont you think that they would have a minute or two to provide an update to shareholders?  Oh wait, maybe its ok for them to just sit around for months and do absolutely nothing.  Heck I have been working from home for 4 months and my employer expects me to work and do something, lol.  The company didnt do anything else for months and they cant provide an update on the folks that were in Phase 1 at least?  I wish i had a job where I didnt have to tell anyone about what I was doing.  Like if my boss called and asked me for an update on my work and I told him to that I would give him an update next year...  This is crazy..
Bullboard Posts